199 related articles for article (PubMed ID: 36835247)
21. Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles.
Hannon MB; Deabold KA; Talsma BN; Lyubimov A; Iqbal A; Zakharov A; Gamble LJ; Wakshlag JJ
J Vet Pharmacol Ther; 2020 Sep; 43(5):508-511. PubMed ID: 32735381
[TBL] [Abstract][Full Text] [Related]
22.
Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
[TBL] [Abstract][Full Text] [Related]
23. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
[TBL] [Abstract][Full Text] [Related]
24. Potency of Δ
Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M
Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid patterns in seedlings of Cannabis sativa L. and their use in the determination of chemical race.
Rowan MG; Fairbairn JW
J Pharm Pharmacol; 1977 Aug; 29(8):491-4. PubMed ID: 19599
[TBL] [Abstract][Full Text] [Related]
27. Phytochemical characterization and biological properties of two standardized extracts from a non-psychotropic Cannabis sativa L. cannabidiol (CBD)-chemotype.
Muscarà C; Smeriglio A; Trombetta D; Mandalari G; La Camera E; Grassi G; Circosta C
Phytother Res; 2021 Sep; 35(9):5269-5281. PubMed ID: 34173287
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G
Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
[TBL] [Abstract][Full Text] [Related]
29. (-)-
Bueno J; Greenbaum EA
J Nat Prod; 2021 Feb; 84(2):531-536. PubMed ID: 33565878
[TBL] [Abstract][Full Text] [Related]
30. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
31. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation.
Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165771. PubMed ID: 32201189
[TBL] [Abstract][Full Text] [Related]
32. In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract.
Śledziński P; Nowak-Terpiłowska A; Rzymski P; Słomski R; Zeyland J
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067615
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Morini L; Porro G; Liso M; Groppi A
Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
[TBL] [Abstract][Full Text] [Related]
34. Cannabidiol Interferes with Establishment of Δ
DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876
[No Abstract] [Full Text] [Related]
35. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
[TBL] [Abstract][Full Text] [Related]
36. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry.
Aizpurua-Olaizola O; Omar J; Navarro P; Olivares M; Etxebarria N; Usobiaga A
Anal Bioanal Chem; 2014 Nov; 406(29):7549-60. PubMed ID: 25338935
[TBL] [Abstract][Full Text] [Related]
37. Application of experimental design in HPLC method optimisation for the simultaneous determination of multiple bioactive cannabinoids.
Durante C; Anceschi L; Brighenti V; Caroli C; Afezolli C; Marchetti A; Cocchi M; Salamone S; Pollastro F; Pellati F
J Pharm Biomed Anal; 2022 Nov; 221():115037. PubMed ID: 36148721
[TBL] [Abstract][Full Text] [Related]
38. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
39. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
40. Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
Zheljazkov VD; Sikora V; Dincheva I; Kačániová M; Astatkie T; Semerdjieva IB; Latkovic D
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
